Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2017-08-01
2018-06-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Microglial Activation in Severe Asthma and Healthy Controls
NCT06299592
AsthMatic Inflammation and Neurocircuitry Activation (MINA)
NCT02764437
Microglia Activation in Asthma
NCT04307667
Neural Mechanisms in Asthma
NCT01155843
The Dallas Asthma Brain and Cognition (ABC) Study
NCT03794856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe Asthmatics
Individuals with severe asthma that are already enrolled in the University of Wisconsin Severe Asthma Research Program III study will fill out asthma and psychological questionnaires (non-diagnostic), will undergo Cognitive Function Testing (non-diagnostic), and will undergo a simulated and actual functional Magnetic Resonance Imaging (research grade) scan.
functional Magnetic Resonance Imaging (research grade)
Subjects will undergo a simulated and actual functional Magnetic Resonance Imaging scan.
Cognitive Function Testing (non-diagnostic)
Subjects will take non-diagnostic cognitive function tests
Asthma and Psychological Questionnaires (non-diagnostic)
Subjects will fill out asthma and psychological questionnaires (non-diagnostic)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
functional Magnetic Resonance Imaging (research grade)
Subjects will undergo a simulated and actual functional Magnetic Resonance Imaging scan.
Cognitive Function Testing (non-diagnostic)
Subjects will take non-diagnostic cognitive function tests
Asthma and Psychological Questionnaires (non-diagnostic)
Subjects will fill out asthma and psychological questionnaires (non-diagnostic)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has severe asthma
* Is a male or female with no health concerns that might affect the outcome of the study
* Provided a negative urine pregnancy test prior to visit (Females only)
* Capable and willing to grant written informed consent and cooperate with study procedures and requirements (investigator discretion)
* Is able to tolerate a simulated functional Magnetic Resonance Imaging brain scanning session
* Is able to give valid informed consent to participate by signing and dating a written consent form
Exclusion Criteria
* Has one or more contraindications for functional Magnetic Resonance Imaging
* Has needle phobia or claustrophobia
* Unable to distinguish specific colors used in Stroop task
* History of a diagnosed Bipolar Disorder, Schizophrenia, or Schizoaffective Disorder
* Is a pregnant or lactating female
* Has had an upper or lower respiratory infection within 1 month of the visit
* Has unstable asthma as indicated by self-report of increased symptoms or increased beta-agonist use over the 2 weeks preceding the visit
* Is a current smoker (defined as smoked within the last year) or a former smoker with a history of \>5 pack years
* Any condition which, in the opinion of the investigator, might interfere with participation in the study
* Inability or unwillingness to perform required study procedures
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William W Busse, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Wisconsin School of Medicine and Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UW Madison
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-0208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.